Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

Recruiting now · Not applicable

Conditions studied: Atherosclerosis, Stress, Inflammation

In brief

The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.

Key facts

Study ID

NCT04496947

Run by

Massachusetts General Hospital

People needed

30

Starts

2018-09-01

Expected to finish

2027-12-31

Last updated by the study team

2026-06-03

Who can join

Age: 30 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• • Aged between 30-65 years
• Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score >5 at baseline, and is interested in participating

You may not qualify if…

• Perceived Stress Scale (PSS) score <6

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.